Yes, that’s the point of a direct comparison. However you can look at existing data for both and get a good idea of relative efficiency / safety, as well. They’re not doing this blind, this trial will be more for marketing than anything. Of course it’s never certain, but I’d say the probabilities substantially lean in our favour for them to go ahead with this
CU6 Price at posting:
$6.73 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)